Epidemiology and molecular pathology of glioma
By J. Schwartzbaum, James L. Fisher, Kenneth D. Aldape, M. Wrensch. Nature Clinical Practice Neurology, 2006
960 citations recorded by the source corpus.
Subfields: Cancer Research, Genetics, Molecular Biology
View Paper: https://www.semanticscholar.org/paper/215a48c33b19ad6cffa9f360e25e53893d3eeeea
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
- Guang Yang
- Hao Dong
- Fangde Liu
- K. Muzaffar
- Yike Guo
- F. Hanif
- Kahkashan Perveen
- Yuanhan Mo
Citations in the corpus
- Glioblastoma Multiforme: A Review of its Epidemiology and Pathogenesis through Clinical Presentation and Treatment (2017, background): “They are the most commonly occurring tumors of the central nervous system (CNS), which account for almost 80% of all malignant primary tumors of brain (Schwartzbaum et al., 2006; Agnihotri et al., 2013; Messali et al., 2014).”
- Molecular profiling reveals biologically discrete subsets and pathways of progression in diffuse glioma (2016, neutral): “Diffuse gliomas represent 80% of malignant brain tumors (Schwartzbaum et al., 2006).”
- Automatic Brain Tumor Detection and Segmentation Using U-Net Based Fully Convolutional Networks (2017, background): “The most frequent primary brain tumors in adults are primary central nervous system lymphomas and gliomas, which the latter account for almost 80% of malignant cases [1].”